US Stock MarketDetailed Quotes

ANVS Annovis Bio

Watchlist
  • 9.060
  • +0.700+8.37%
Trading May 15 14:54 ET
101.21MMarket Cap-1572P/E (TTM)

Annovis Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-21.66%7.81M
76.53%45.04M
33.87%10.44M
129.20%14.86M
63.41%9.76M
89.77%9.97M
75.93%25.51M
31.76%7.8M
127.24%6.48M
136.37%5.97M
Selling and administrative expenses
-40.70%1.29M
-30.58%6.24M
-3.41%1.54M
-56.57%1.03M
-22.75%1.5M
-29.65%2.18M
48.49%9M
-47.56%1.59M
60.31%2.36M
173.16%1.94M
-General and administrative expense
-40.70%1.29M
-30.58%6.24M
-3.41%1.54M
-56.57%1.03M
-22.75%1.5M
-29.65%2.18M
48.49%9M
-47.56%1.59M
60.31%2.36M
173.16%1.94M
Research and development costs
-16.33%6.51M
134.87%38.79M
43.43%8.9M
235.58%13.84M
104.82%8.26M
262.20%7.79M
94.78%16.52M
115.26%6.21M
198.63%4.12M
121.10%4.03M
Provision for doubtful accounts
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Operating profit
21.66%-7.81M
-76.53%-45.04M
-33.87%-10.44M
-129.20%-14.86M
-63.41%-9.76M
-89.77%-9.97M
-75.93%-25.51M
-31.76%-7.8M
-127.24%-6.48M
-136.37%-5.97M
Net non-operating interest income expense
-81.01%44.17K
265.55%667.9K
-10.82%66.13K
177.30%146.66K
517.86%222.58K
1,083.44%232.54K
1,270.17%182.71K
1,260.61%74.15K
852.21%52.89K
1,588.10%36.02K
Non-operating interest income
-81.01%44.17K
265.55%667.9K
-10.82%66.13K
177.30%146.66K
----
1,083.44%232.54K
1,270.17%182.71K
1,260.61%74.15K
852.21%52.89K
----
Total other finance cost
----
----
----
----
-517.86%-222.58K
----
----
----
----
---36.02K
Other net income (expense)
6.7M
-11.84M
Gain on sale of security
--6.7M
---11.84M
----
----
----
----
----
----
----
----
Income before tax
89.04%-1.07M
-121.90%-56.2M
-187.51%-22.21M
-128.80%-14.72M
-60.66%-9.54M
-86.03%-9.74M
-74.83%-25.33M
-30.63%-7.73M
-125.82%-6.43M
-135.14%-5.94M
Income tax
Net income
89.04%-1.07M
-121.90%-56.2M
-187.51%-22.21M
-128.80%-14.72M
-60.66%-9.54M
-86.03%-9.74M
-74.83%-25.33M
-30.63%-7.73M
-125.82%-6.43M
-135.14%-5.94M
Net income continuous Operations
89.04%-1.07M
-121.90%-56.2M
-187.51%-22.21M
-128.80%-14.72M
-60.66%-9.54M
-86.03%-9.74M
-74.83%-25.33M
-30.63%-7.73M
-125.82%-6.43M
-135.14%-5.94M
Minority interest income
Net income attributable to the parent company
89.04%-1.07M
-121.90%-56.2M
-187.51%-22.21M
-128.80%-14.72M
-60.66%-9.54M
-86.03%-9.74M
-74.83%-25.33M
-30.63%-7.73M
-125.82%-6.43M
-135.14%-5.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
89.04%-1.07M
-121.90%-56.2M
-187.51%-22.21M
-128.80%-14.72M
-60.66%-9.54M
-86.03%-9.74M
-74.83%-25.33M
-30.63%-7.73M
-125.82%-6.43M
-135.14%-5.94M
Basic earnings per share
91.60%-0.1
-100.97%-6.23
-147.87%-2.33
-106.33%-1.63
-46.58%-1.07
-85.94%-1.19
-63.16%-3.1
-25.33%-0.94
-125.71%-0.79
-114.71%-0.73
Diluted earnings per share
91.60%-0.1
-100.97%-6.23
-147.87%-2.33
-106.33%-1.63
-46.58%-1.07
-85.94%-1.19
-63.16%-3.1
-25.33%-0.94
-125.71%-0.79
-114.71%-0.73
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -21.66%7.81M76.53%45.04M33.87%10.44M129.20%14.86M63.41%9.76M89.77%9.97M75.93%25.51M31.76%7.8M127.24%6.48M136.37%5.97M
Selling and administrative expenses -40.70%1.29M-30.58%6.24M-3.41%1.54M-56.57%1.03M-22.75%1.5M-29.65%2.18M48.49%9M-47.56%1.59M60.31%2.36M173.16%1.94M
-General and administrative expense -40.70%1.29M-30.58%6.24M-3.41%1.54M-56.57%1.03M-22.75%1.5M-29.65%2.18M48.49%9M-47.56%1.59M60.31%2.36M173.16%1.94M
Research and development costs -16.33%6.51M134.87%38.79M43.43%8.9M235.58%13.84M104.82%8.26M262.20%7.79M94.78%16.52M115.26%6.21M198.63%4.12M121.10%4.03M
Provision for doubtful accounts --0--0--0--0--0--0--0--0--0--0
Operating profit 21.66%-7.81M-76.53%-45.04M-33.87%-10.44M-129.20%-14.86M-63.41%-9.76M-89.77%-9.97M-75.93%-25.51M-31.76%-7.8M-127.24%-6.48M-136.37%-5.97M
Net non-operating interest income expense -81.01%44.17K265.55%667.9K-10.82%66.13K177.30%146.66K517.86%222.58K1,083.44%232.54K1,270.17%182.71K1,260.61%74.15K852.21%52.89K1,588.10%36.02K
Non-operating interest income -81.01%44.17K265.55%667.9K-10.82%66.13K177.30%146.66K----1,083.44%232.54K1,270.17%182.71K1,260.61%74.15K852.21%52.89K----
Total other finance cost -----------------517.86%-222.58K-------------------36.02K
Other net income (expense) 6.7M-11.84M
Gain on sale of security --6.7M---11.84M--------------------------------
Income before tax 89.04%-1.07M-121.90%-56.2M-187.51%-22.21M-128.80%-14.72M-60.66%-9.54M-86.03%-9.74M-74.83%-25.33M-30.63%-7.73M-125.82%-6.43M-135.14%-5.94M
Income tax
Net income 89.04%-1.07M-121.90%-56.2M-187.51%-22.21M-128.80%-14.72M-60.66%-9.54M-86.03%-9.74M-74.83%-25.33M-30.63%-7.73M-125.82%-6.43M-135.14%-5.94M
Net income continuous Operations 89.04%-1.07M-121.90%-56.2M-187.51%-22.21M-128.80%-14.72M-60.66%-9.54M-86.03%-9.74M-74.83%-25.33M-30.63%-7.73M-125.82%-6.43M-135.14%-5.94M
Minority interest income
Net income attributable to the parent company 89.04%-1.07M-121.90%-56.2M-187.51%-22.21M-128.80%-14.72M-60.66%-9.54M-86.03%-9.74M-74.83%-25.33M-30.63%-7.73M-125.82%-6.43M-135.14%-5.94M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 89.04%-1.07M-121.90%-56.2M-187.51%-22.21M-128.80%-14.72M-60.66%-9.54M-86.03%-9.74M-74.83%-25.33M-30.63%-7.73M-125.82%-6.43M-135.14%-5.94M
Basic earnings per share 91.60%-0.1-100.97%-6.23-147.87%-2.33-106.33%-1.63-46.58%-1.07-85.94%-1.19-63.16%-3.1-25.33%-0.94-125.71%-0.79-114.71%-0.73
Diluted earnings per share 91.60%-0.1-100.97%-6.23-147.87%-2.33-106.33%-1.63-46.58%-1.07-85.94%-1.19-63.16%-3.1-25.33%-0.94-125.71%-0.79-114.71%-0.73
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.67%